News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
195,264 Results
Type
Article (9355)
Company Profile (22)
Press Release (185884)
Multimedia
Podcasts (5)
Webinars (2)
Section
Business (58991)
Career Advice (656)
Deals (11209)
Drug Delivery (21)
Drug Development (29059)
Employer Resources (40)
FDA (4976)
Job Trends (4583)
News (101965)
Policy (8115)
Tag
Academia (505)
Accelerated approval (4)
Adcomms (6)
Allergies (51)
Alliances (7926)
ALS (69)
Alzheimer's disease (632)
Antibody-drug conjugate (ADC) (86)
Approvals (5138)
Artificial intelligence (190)
Autoimmune disease (32)
Automation (11)
Bankruptcy (78)
Best Places to Work (4096)
BIOSECURE Act (3)
Biosimilars (89)
Biotechnology (20)
Bladder cancer (92)
Brain cancer (22)
Breast cancer (306)
Cancer (2095)
Cardiovascular disease (159)
Career advice (534)
Career pathing (8)
CAR-T (89)
CDC (7)
Cell therapy (247)
Cervical cancer (18)
Clinical research (26640)
Collaboration (594)
Company closure (1)
Compensation (465)
Complete response letters (8)
COVID-19 (862)
CRISPR (30)
C-suite (205)
Cystic fibrosis (49)
Data (2650)
Denatured (1)
Depression (41)
Diabetes (204)
Diagnostics (1899)
Digital health (15)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (67)
Drug pricing (37)
Drug shortages (11)
Duchenne muscular dystrophy (112)
Earnings (46389)
Editorial (13)
Employer branding (8)
Employer resources (35)
Events (29195)
Executive appointments (421)
FDA (6347)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (548)
Gene editing (63)
Generative AI (5)
Gene therapy (203)
GLP-1 (404)
Government (1171)
Grass and pollen (3)
Guidances (322)
Healthcare (5309)
HIV (31)
Huntington's disease (11)
IgA nephropathy (25)
Immunology and inflammation (81)
Immuno-oncology (4)
Indications (33)
Infectious disease (964)
Inflammatory bowel disease (66)
Inflation Reduction Act (3)
Influenza (38)
Intellectual property (61)
Interviews (125)
IPO (7166)
IRA (13)
Job creations (785)
Job search strategy (463)
Kidney cancer (10)
Labor market (26)
Layoffs (145)
Leadership (3)
Legal (1482)
Liver cancer (36)
Longevity (2)
Lung cancer (332)
Lymphoma (169)
Machine learning (11)
Management (10)
Manufacturing (210)
MASH (60)
Medical device (4144)
Medtech (4153)
Mergers & acquisitions (4517)
Metabolic disorders (485)
Multiple sclerosis (90)
NASH (6)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1104)
NextGen: Class of 2025 (1483)
Non-profit (1057)
Now hiring (10)
Obesity (219)
Opinion (45)
Ovarian cancer (61)
Pain (59)
Pancreatic cancer (87)
Parkinson's disease (117)
Partnered (4)
Patents (146)
Patient recruitment (133)
Peanut (22)
People (7027)
Pharmaceutical (7)
Pharmacy benefit managers (10)
Phase I (6904)
Phase II (11427)
Phase III (10399)
Pipeline (1926)
Policy (43)
Postmarket research (1068)
Preclinical (2167)
Press Release (27)
Prostate cancer (111)
Psychedelics (7)
Radiopharmaceuticals (82)
Rare diseases (261)
Real estate (905)
Recruiting (16)
Regulatory (6860)
Reports (16)
Research institute (498)
Resumes & cover letters (111)
Rett syndrome (13)
RNA editing (1)
RSV (35)
Schizophrenia (70)
Series A (84)
Series B (74)
Service/supplier (3)
Sickle cell disease (41)
Special edition (7)
Spinal muscular atrophy (87)
Sponsored (9)
Startups (635)
State (1)
Stomach cancer (6)
Supply chain (50)
Tariffs (17)
The Weekly (4)
Vaccines (359)
Venture capital (21)
Weight loss (146)
Women's health (21)
Worklife (8)
Date
Today (53)
Last 7 days (260)
Last 30 days (1200)
Last 365 days (17070)
2025 (13266)
2024 (14759)
2023 (14315)
2022 (16776)
2021 (16234)
2020 (15541)
2019 (12785)
2018 (9784)
2017 (9333)
2016 (7966)
2015 (9632)
2014 (7086)
2013 (5215)
2012 (5911)
2011 (6161)
2010 (5233)
Location
Africa (218)
Alabama (15)
Alaska (2)
Arizona (62)
Arkansas (5)
Asia (12448)
Australia (2157)
California (4777)
Canada (1224)
China (416)
Colorado (197)
Connecticut (254)
Delaware (185)
Europe (30403)
Florida (544)
Georgia (123)
Hawaii (2)
Idaho (12)
Illinois (351)
India (20)
Indiana (198)
Iowa (11)
Japan (213)
Kansas (57)
Kentucky (14)
Louisiana (8)
Maine (39)
Maryland (470)
Massachusetts (3544)
Michigan (93)
Minnesota (239)
Mississippi (1)
Missouri (56)
Montana (11)
Nebraska (4)
Nevada (60)
New Hampshire (29)
New Jersey (1391)
New Mexico (5)
New York (1231)
North Carolina (602)
North Dakota (3)
Northern California (2233)
Ohio (113)
Oklahoma (5)
Oregon (10)
Pennsylvania (863)
Puerto Rico (4)
Rhode Island (17)
South America (322)
South Carolina (12)
Southern California (1801)
Tennessee (61)
Texas (698)
United States (16585)
Utah (107)
Virginia (117)
Washington D.C. (34)
Washington State (395)
West Virginia (2)
Wisconsin (64)
195,264 Results for "6".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gynecology Drugs Market Size to Reach USD 112.6 Billion by 2034 Rising Gynecological Disorders and Health Awareness Drive Market Growth
The global gynecology drugs market size is forecasted to reach around USD 112.6 billion by 2034, increasing from USD 69.79 billion in 2024 and representing a remarkable CAGR of 4.9% from 2025 to 2034.
October 16, 2025
·
1 min read
Layoffs
Layoffs From Just 6 Pharmas Could Wipe Out Over 39,000 Jobs
This year, Novo Nordisk and Merck announced significant layoffs, with Novo planning to axe about 9,000 employees and Merck projecting it could let go of roughly 6,000. Meanwhile, Bayer, Bristol Myers Squibb, Novartis and Pfizer have also made noteworthy cuts.
September 18, 2025
·
9 min read
·
Angela Gabriel
Job Trends
6 Companies Hiring Now in Boston
Looking for a biopharma job in Boston? Check out the
BioSpace
list of six companies hiring life sciences professionals like you.
October 2, 2025
·
1 min read
·
Angela Gabriel
Job Trends
6 Companies Hiring Now in Pennsylvania
Looking for a biopharma job in Pennsylvania? Check out the
BioSpace
list of six companies hiring life sciences professionals like you.
September 25, 2025
·
1 min read
·
Angela Gabriel
Regulatory
6 FDA Decisions To Watch For in Q4
From more than 30 target action dates in the last three months of the year,
BioSpace
has narrowed the list to six regulatory decisions that could have far-reaching implications for biopharma and patients.
September 29, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Equillium Announces Leadership and Corporate Updates - October 6, 2025
October 6, 2025
·
4 min read
Job Trends
6 Companies Hiring in Texas
Looking for a biopharma job in Texas? Check out the
BioSpace
list of six companies hiring life sciences professionals like you.
August 14, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
October 17, 2025
·
1 min read
Podcast
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More
George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest rejection reportedly driven by FDA’s top cancer regulator Richard Pazdur; Merck’s $3 billion savings push claims 6,000 jobs; and Pfizer CEO Albert Bourla addresses President Donald Trump’s new threats around Most Favored Nation drug pricing.
August 6, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock
October 16, 2025
·
2 min read
1 of 19,527
Next
